Clinical Study
Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine
Table 3
The most frequently observed AEs in both treatment groups (at least three events in one treatment group).
| System organ class—type of AE | EGb 761 () | Betahistine () |
| Gastrointestinal disorders: | | | Dyspepsia and abdominal discomfort/pain | 2 | 5 | Nausea and vomiting | 3 | 1 | Diarrhea, frequent bowel movements infections, and infestations | 1 | 3 | Respiratory tract infections and nervous system disorders | 5 | 9 | Headache | 3 | 5 |
|
|